Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emera Inc.

46.69
+0.05000.11%
Volume:11.25K
Turnover:524.78K
Market Cap:13.91B
PE:22.57
High:46.71
Open:46.44
Low:46.42
Close:46.64
Loading ...

Annexon Announces Completion of Enrollment in Pivotal Phase 3 ARCHER II Trial of Vonaprument (formerly ANX007) for Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy

GlobeNewswire
·
4 hours ago

Flare (FLR) Jumps 15% as Volume Soars—Is a Major Rally Brewing?

BE[IN]CRYPTO
·
Yesterday

Pi Coin Teases a Quick 40% Burst If This One EMA Cross Confirms

BE[IN]CRYPTO
·
Yesterday

Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis

GlobeNewswire
·
Yesterday

3 CoinGecko Top Gainers to Watch for the Fourth Week of July

BE[IN]CRYPTO
·
22 Jul

Bank of America Securities Reaffirms Their Buy Rating on Emera (EMA)

TIPRANKS
·
21 Jul

Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110

GlobeNewswire
·
21 Jul

Shiba Inu (SHIB): Fundamental Shift, XRP Sky Is Not Limit Now, Bitcoin (BTC) Price Cools Down

utoday
·
21 Jul

HBAR Price Rallies 20% After $230 Million Inflow from Traders in a Week

BE[IN]CRYPTO
·
18 Jul

Zevra Therapeutics Announces MIPLYFFA® and OLPRUVA® Presentations at the Annual Meeting of the Southeastern Regional Genetics Group (SERGG)

GlobeNewswire
·
18 Jul

BMO Capital Sticks to Its Buy Rating for Emera (EMA)

TIPRANKS
·
18 Jul

Press Release: Emera Incorporated Announces Dividend Rates for Series A and Series B First Preferred Shares

Dow Jones
·
17 Jul

Zevra Therapeutics Announces Open Label Extension Data Showing Sustained Long-Term Efficacy of MIPLYFFA for the Treatment of NPC Published in the Journal of Molecular Genetics and Metabolism

GlobeNewswire
·
16 Jul

Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film

GlobeNewswire
·
15 Jul

Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)

GlobeNewswire
·
14 Jul

Valneva’s Chikungunya Vaccine Restriction Lifted by EMA

TIPRANKS
·
12 Jul

Ethena (ENA) Hits 30-Day High as Spot and Futures Demand Surge

BE[IN]CRYPTO
·
11 Jul

Zevra Therapeutics Announces MIPLYFFA® (arimoclomol) Featured in Presentations at the National Niemann Pick Disease Foundation Conference

GlobeNewswire
·
11 Jul

Press Release: Emera Declares Quarterly Dividends

Dow Jones
·
11 Jul

Cardano Shorts' Bloodbath Triggers 4,146% Liquidation Imbalance in One Hour

utoday
·
11 Jul